VRXA

Veraxa Biotech AG

Healthcare · Biotechnology

1.10$ -5.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in CHF.

Tick rows to compare them in a chart (up to 4)

Cash Flow VRXA
Line item	2023	2024	2025
Operating Cash Flow	-0.05	-0.05	-0.07
Depreciation & Amortization	0.01	0.01	0.01
Stock-Based Compensation	0.05	0.13	0.37
Change in Working Capital	0.00	0.00	0.01
Capital Expenditures	0.00	0.00	0.00
Net Borrowings	–	0.00	0.01
Financing Cash Flow	0.09	0.01	0.05
Change in Cash	0.03	-0.04	-0.03
Free Cash Flow	-0.05	-0.06	-0.07

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.